U.S. drugs giant Amgen buys out Mustafa Nevzat for $700 million.
U.S. drugs giant Amgen has announced that it has agreed to buy out Turkish Mustafa Nevzat for $700 million. Amgen
Read More
U.S. drugs giant Amgen has announced that it has agreed to buy out Turkish Mustafa Nevzat for $700 million. Amgen
Read More